Provided by Tiger Fintech (Singapore) Pte. Ltd.

iSpecimen Inc.

1.25
-0.0250-1.96%
Pre-market: 1.250.00000.00%08:00 EDT
Volume:51.48K
Turnover:61.67K
Market Cap:3.12M
PE:-0.07
High:1.26
Open:1.26
Low:1.15
Close:1.28
Loading ...

iSpecimen Inc. Delays Q1 2025 Financial Report Filing Due to Unforeseen Challenges

Reuters
·
16 May

iSpecimen files to sell 2.36M shares of common stock

TIPRANKS
·
03 May

iSpecimen Delays Yearly Report Due to Auditor Change

TIPRANKS
·
27 Mar

iSpecimen Inc - on Feb 19, Richard Paolone Appointed as Chair of the Board

THOMSON REUTERS
·
24 Feb

Top Premarket Gainers

MT Newswires Live
·
24 Feb

iSpecimen Shares up 17.5% at $3.34 as Co Secures Suppliers for Flu-Like Human Metapneumovirus (Hmpv)

THOMSON REUTERS
·
17 Jan

iSpecimen Shares up 34% at $3.81 Premarket as Co Secures Suppliers for Flu-Like Human Metapneumovirus (Hmpv)

THOMSON REUTERS
·
17 Jan

iSpecimen Shares Rise After Securring Virus Suppliers

Dow Jones
·
17 Jan

BRIEF-iSpecimen Secures Suppliers For Flu-Like Human Metapneumovirus (HMPV)

Reuters
·
17 Jan

iSpecimen Inc - Secures Suppliers for Flu-Like Human Metapneumovirus (Hmpv)

THOMSON REUTERS
·
17 Jan

iSpecimen Secures Suppliers for COVID-style hMPV Outbreak

Newsfile
·
17 Jan

iSpecimen Inc. (NASDAQ:ISPC) Looks Inexpensive After Falling 38% But Perhaps Not Attractive Enough

Simply Wall St.
·
01 Jan

iSpecimen Strengthens Leadership and Expands Cancer Research Focus

TIPRANKS
·
21 Dec 2024

BRIEF-Ispecimen Inc On Dec 13, Board Appointed Yuying Liang As CFO

Reuters
·
21 Dec 2024

iSpecimen Inc: on Dec 13, Board Appointed Yuying Liang as CFO

THOMSON REUTERS
·
21 Dec 2024

iSpecimen Inc: Will Serve as a Preferred Provider of Cancer Biospecimens

THOMSON REUTERS
·
21 Dec 2024

iSpecimen Will Serve as a Preferred Provider of Cancer Biospecimens

Newsfile
·
20 Dec 2024

iSpecimen Reports Positive Results on Next Day Quote Program for Researchers and Providers

Newsfile
·
13 Dec 2024

iSpecimen Appoints Robert Lim as New CEO

TIPRANKS
·
13 Dec 2024

iSpecimen Inc: Appoints Robert Lim as CEO and Director

THOMSON REUTERS
·
13 Dec 2024